ANDLAUER HEALTHCARE GROUP IN (AND.CA) Fundamental Analysis & Valuation

TSX:AND • CA0342231077

54.97 CAD
+0.01 (+0.02%)
Last: Nov 4, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AND.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall AND gets a fundamental rating of 6 out of 10. We evaluated AND against 13 industry peers in the Health Care Providers & Services industry. AND gets an excellent profitability rating and is at the same time showing great financial health properties. AND is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. AND.CA Profitability Analysis

1.1 Basic Checks

  • AND had positive earnings in the past year.
  • AND had a positive operating cash flow in the past year.
  • AND had positive earnings in each of the past 5 years.
  • In the past 5 years AND always reported a positive cash flow from operatings.
AND.CA Yearly Net Income VS EBIT VS OCF VS FCFAND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.81%, AND is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 15.35%, AND belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 11.76%, AND belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AND is above the industry average of 7.68%.
Industry RankSector Rank
ROA 9.81%
ROE 15.35%
ROIC 11.76%
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
AND.CA Yearly ROA, ROE, ROICAND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • The Profit Margin of AND (10.37%) is better than 86.67% of its industry peers.
  • AND's Profit Margin has been stable in the last couple of years.
  • AND's Operating Margin of 13.99% is amongst the best of the industry. AND outperforms 86.67% of its industry peers.
  • In the last couple of years the Operating Margin of AND has remained more or less at the same level.
  • AND has a worse Gross Margin (33.85%) than 60.00% of its industry peers.
  • AND's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.99%
PM (TTM) 10.37%
GM 33.85%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
AND.CA Yearly Profit, Operating, Gross MarginsAND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. AND.CA Health Analysis

2.1 Basic Checks

  • AND has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, AND has less shares outstanding
  • Compared to 5 years ago, AND has more shares outstanding
  • Compared to 1 year ago, AND has a worse debt to assets ratio.
AND.CA Yearly Shares OutstandingAND.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AND.CA Yearly Total Debt VS Total AssetsAND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • AND has an Altman-Z score of 6.13. This indicates that AND is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of AND (6.13) is better than 93.33% of its industry peers.
  • The Debt to FCF ratio of AND is 1.80, which is an excellent value as it means it would take AND, only 1.80 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AND (1.80) is better than 100.00% of its industry peers.
  • AND has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • AND has a better Debt to Equity ratio (0.21) than 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.8
Altman-Z 6.13
ROIC/WACC1.44
WACC8.16%
AND.CA Yearly LT Debt VS Equity VS FCFAND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

  • AND has a Current Ratio of 1.35. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
  • AND has a Current ratio of 1.35. This is amongst the best in the industry. AND outperforms 93.33% of its industry peers.
  • A Quick Ratio of 1.30 indicates that AND should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.30, AND belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.3
AND.CA Yearly Current Assets VS Current LiabilitesAND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AND.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.96% over the past year.
  • AND shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.82% yearly.
  • AND shows a small growth in Revenue. In the last year, the Revenue has grown by 0.34%.
  • The Revenue has been growing by 17.53% on average over the past years. This is quite good.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.62% on average over the next years. This is quite good.
  • AND is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.95% yearly.
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AND.CA Yearly Revenue VS EstimatesAND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
AND.CA Yearly EPS VS EstimatesAND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

3

4. AND.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 35.24 indicates a quite expensive valuation of AND.
  • Compared to the rest of the industry, the Price/Earnings ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 66.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.46, AND is valued a bit more expensive.
  • A Price/Forward Earnings ratio of 28.68 indicates a quite expensive valuation of AND.
  • 73.33% of the companies in the same industry are more expensive than AND, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 24.65. AND is around the same levels.
Industry RankSector Rank
PE 35.24
Fwd PE 28.68
AND.CA Price Earnings VS Forward Price EarningsAND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AND is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • AND's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.69
EV/EBITDA 14.03
AND.CA Per share dataAND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AND does not grow enough to justify the current Price/Earnings ratio.
  • AND has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.39
PEG (5Y)2.38
EPS Next 2Y10.13%
EPS Next 3Y8.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. AND.CA Dividend Analysis

5.1 Amount

  • AND has a yearly dividend return of 0.87%, which is pretty low.
  • AND's Dividend Yield is a higher than the industry average which is at 1.37.
  • Compared to an average S&P500 Dividend Yield of 1.82, AND's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

  • The dividend of AND decreases each year by -34.89%.
  • AND has been paying a dividend for over 5 years, so it has already some track record.
  • AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
AND.CA Yearly Dividends per shareAND.CA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • AND pays out 26.73% of its income as dividend. This is a sustainable payout ratio.
DP26.73%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
AND.CA Yearly Income VS Free CF VS DividendAND.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AND.CA Dividend Payout.AND.CA Dividend Payout, showing the Payout Ratio.AND.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AND.CA Fundamentals: All Metrics, Ratios and Statistics

ANDLAUER HEALTHCARE GROUP IN

TSX:AND (11/4/2025, 7:00:00 PM)

54.97

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11
Earnings (Next)02-24
Inst Owners76.5%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap2.15B
Revenue(TTM)650.58M
Net Income(TTM)67.49M
Analysts50
Price Target56.92 (3.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP26.73%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.25%
Min EPS beat(2)-19.85%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.2%
Min EPS beat(4)-19.85%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-8.84%
EPS beat(12)3
Avg EPS beat(12)-6.41%
EPS beat(16)5
Avg EPS beat(16)11.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-7.25%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-7.25%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.43%
EPS NY rev (1m)-0.79%
EPS NY rev (3m)-6.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.5%
Valuation
Industry RankSector Rank
PE 35.24
Fwd PE 28.68
P/S 3.31
P/FCF 21.69
P/OCF 17.59
P/B 4.89
P/tB 17.04
EV/EBITDA 14.03
EPS(TTM)1.56
EY2.84%
EPS(NY)1.92
Fwd EY3.49%
FCF(TTM)2.53
FCFY4.61%
OCF(TTM)3.13
OCFY5.69%
SpS16.62
BVpS11.23
TBVpS3.23
PEG (NY)5.39
PEG (5Y)2.38
Graham Number19.86
Profitability
Industry RankSector Rank
ROA 9.81%
ROE 15.35%
ROCE 16.09%
ROIC 11.76%
ROICexc 13.13%
ROICexgc 34.45%
OM 13.99%
PM (TTM) 10.37%
GM 33.85%
FCFM 15.25%
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexgc growth 3Y-1.36%
ROICexgc growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.8
Debt/EBITDA 0.56
Cap/Depr 32.65%
Cap/Sales 3.56%
Interest Coverage 250
Cash Conversion 75.6%
Profit Quality 147.02%
Current Ratio 1.35
Quick Ratio 1.3
Altman-Z 6.13
F-Score5
WACC8.16%
ROIC/WACC1.44
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
EBIT growth 1Y-1.92%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year74.49%
EBIT Next 3Y25.3%
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-1.91%
OCF growth 3Y13.94%
OCF growth 5Y15.32%

ANDLAUER HEALTHCARE GROUP IN / AND.CA FAQ

What is the ChartMill fundamental rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to AND.CA.


What is the valuation status of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?

ChartMill assigns a valuation rating of 3 / 10 to ANDLAUER HEALTHCARE GROUP IN (AND.CA). This can be considered as Overvalued.


How profitable is ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?

ANDLAUER HEALTHCARE GROUP IN (AND.CA) has a profitability rating of 7 / 10.


What is the earnings growth outlook for ANDLAUER HEALTHCARE GROUP IN?

The Earnings per Share (EPS) of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is expected to grow by 6.54% in the next year.


Is the dividend of ANDLAUER HEALTHCARE GROUP IN sustainable?

The dividend rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 3 / 10 and the dividend payout ratio is 26.73%.